Clearpoint Neuro Net Income Over Time
| CLPT Stock | USD 13.59 0.52 3.69% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Clearpoint Neuro Performance and Clearpoint Neuro Correlation. Clearpoint | Build AI portfolio with Clearpoint Stock |
Is there potential for Health Care Equipment & Supplies market expansion? Will Clearpoint introduce new products? Factors like these will boost the valuation of Clearpoint Neuro. Projected growth potential of Clearpoint fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Clearpoint Neuro listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.80) | Revenue Per Share | Quarterly Revenue Growth 0.091 | Return On Assets | Return On Equity |
The market value of Clearpoint Neuro is measured differently than its book value, which is the value of Clearpoint that is recorded on the company's balance sheet. Investors also form their own opinion of Clearpoint Neuro's value that differs from its market value or its book value, called intrinsic value, which is Clearpoint Neuro's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Clearpoint Neuro's market value can be influenced by many factors that don't directly affect Clearpoint Neuro's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Clearpoint Neuro's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Clearpoint Neuro should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Clearpoint Neuro's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Cross Equities Net Income Analysis
Compare Clearpoint Neuro and related stocks such as Si Bone, Avanos Medical, and Varex Imaging Corp Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SIBN | (10.9 M) | (10.9 M) | (10.9 M) | (6.2 M) | (27.8 M) | (28.2 M) | (20.6 M) | (23 M) | (17.5 M) | (38.4 M) | (43.7 M) | (56.6 M) | (61.3 M) | (43.3 M) | (30.9 M) | (27.8 M) | (29.2 M) |
| AVNS | 142.4 M | 142.4 M | 152.6 M | 154.6 M | 27.1 M | (426.3 M) | 39.8 M | 79.3 M | 57.5 M | (45.9 M) | (27.2 M) | 6.3 M | 50.5 M | (61.8 M) | (392.1 M) | (352.9 M) | (335.2 M) |
| VREX | 109.6 M | 109.6 M | 109.6 M | 110.1 M | 80 M | 68.5 M | 51.6 M | 27.5 M | 15.5 M | (57.9 M) | 17.4 M | 30.3 M | 48.2 M | (47.7 M) | (69.9 M) | (62.9 M) | (59.8 M) |
| OFIX | 5 M | (1.1 M) | 51.3 M | (28.5 M) | (8.5 M) | (2.8 M) | 3.1 M | 6.2 M | 13.8 M | (28.5 M) | 2.5 M | (38.4 M) | (19.7 M) | (151.4 M) | (126 M) | (113.4 M) | (107.7 M) |
| CMPS | (13.2 M) | (13.2 M) | (13.2 M) | (13.2 M) | (13.2 M) | (13.2 M) | (13.2 M) | (13.2 M) | (13.2 M) | (19.6 M) | (60.8 M) | (71.7 M) | (91.5 M) | (118.5 M) | (155.1 M) | (139.6 M) | (132.6 M) |
| CTKB | (16.8 M) | (16.8 M) | (16.8 M) | (16.8 M) | (16.8 M) | (16.8 M) | (16.8 M) | (16.8 M) | (16.8 M) | (16.8 M) | 19.4 M | 3 M | 2.6 M | (12.1 M) | (6 M) | (5.4 M) | (5.1 M) |
| LAB | (23.6 M) | (22.5 M) | (19 M) | (15.8 M) | (52.8 M) | (53.3 M) | (76 M) | (60.5 M) | (59 M) | (64.8 M) | (53 M) | (59.2 M) | (190.1 M) | (74.7 M) | (138.9 M) | (125 M) | (118.7 M) |
| SNDL | (1.5 M) | (1.5 M) | (1.5 M) | (1.5 M) | (1.5 M) | (1.5 M) | (1.5 M) | (13 M) | (3 M) | (271.5 M) | (233.2 M) | (227 M) | (335.1 M) | (172.7 M) | (94.8 M) | (85.3 M) | (89.6 M) |
| AKBA | (8.2 M) | (8.2 M) | (8.2 M) | (13.2 M) | (37 M) | (60.7 M) | (135.7 M) | (76.9 M) | (171.9 M) | (279.7 M) | (349.9 M) | (244.9 M) | (94.2 M) | (51.9 M) | (69.4 M) | (62.5 M) | (65.6 M) |
Clearpoint Neuro and related stocks such as Si Bone, Avanos Medical, and Varex Imaging Corp Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Clearpoint Neuro financial statement analysis. It represents the amount of money remaining after all of Clearpoint Neuro operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| Clearpoint Neuro | CLPT |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | 120 S Sierra |
| Exchange | NASDAQ Exchange |
USD 13.59
Additional Tools for Clearpoint Stock Analysis
When running Clearpoint Neuro's price analysis, check to measure Clearpoint Neuro's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearpoint Neuro is operating at the current time. Most of Clearpoint Neuro's value examination focuses on studying past and present price action to predict the probability of Clearpoint Neuro's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearpoint Neuro's price. Additionally, you may evaluate how the addition of Clearpoint Neuro to your portfolios can decrease your overall portfolio volatility.